AbCellera Biologics Inc. ABCL Change in receivables
Change in receivables at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s change in receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s change in receivables?
- AbCellera Biologics Inc. (ABCL) reported change in receivables of -$13.1M in Q1 2026.
- How has AbCellera Biologics Inc.'s change in receivables changed year-over-year?
- AbCellera Biologics Inc.'s change in receivables decreased by 1256.5% year-over-year, from $1.13M to -$13.1M.
- What is the long-term trend for AbCellera Biologics Inc.'s change in receivables?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s change in receivables has grown at a 12.4% compound annual growth rate (CAGR), from $39.12M to $55.62M.
- What does change in receivables mean?
- Change in total receivables including trade and non-trade receivables.